Table 1.
Gene | APOE ε2/ε3 | APOE ε3/ε3 | APOE ε3/ε4 | Total | ||||
---|---|---|---|---|---|---|---|---|
Z | P value | Z | P value | Z | P value | Z | P value | |
C4A | 4.28 | 1.9 × 10−5 | 2.78 | 5.4 × 10−3 | 2.48 | 0.01 | 5.73 | 1.0 × 10−8 |
C4B | 4.10 | 4.2 × 10−5 | 3.50 | 4.7 × 10−4 | 2.17 | 0.03 | 6.08 | 1.2 × 10−9 |
GFAP | 4.12 | 3.8 × 10−5 | 4.03 | 5.6 × 10−5 | 1.51 | 0.13 | 6.89 | 5.4 × 10−12 |
NPNT | 3.65 | 2.6 × 10−4 | 6.34 | 2.4 × 10−10 | 1.58 | 0.11 | 8.58 | 9.3 × 10−18 |
Gene expression levels were compared between AD and control brains separately in the ROSMAP, MAYO, and FHS/BUADC datasets, and results were combined by meta-analysis.
Selected genes surpassed significance thresholds p < 10−3 in the APOE 2/ε3 group and p < 10−6 in the total sample.